Tricuspid Atresia

10 registered clinical trials studyying Tricuspid Atresia — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Two-Year Study of the Safety and Efficacy of the Second-Generation Tissue Engineered Vascular Grafts NCT04467671	Nationwide Children's Hospital	Phase 2
Recruiting	NIRS in Congenital Heart Defects - Correlation With Echocardiography NCT04106479	McGill University Health Centre/Research Institute of the McGill University Health Centre	—
Terminated	Methacetin Breath Test in Patients With Liver Disease Secondary to Heart Disease NCT04176458	Northwestern University	N/A
Completed	Study of Placebo or Bosentan to Treat Patients With Single Ventricle Physiology. NCT01292551	Rigshospitalet, Denmark	Phase 2
Terminated	Global and Regional Myocardial Strain and Power Output In Patients With Single Ventricles Using Novel MRI Tech NCT01107990	University of California, San Francisco	—
Completed	Impact of Vitamin C on Endothelial Function and Exercise Capacity in Fontan-Palliated Patients NCT00974025	University of Michigan	N/A
Completed	Sildenafil After the Fontan Operation NCT00507819	Children's Hospital of Philadelphia	Phase 2
Completed	Biomarker Study for Heart Failure in Children With Single Ventricle Physiology NCT00571233	University of California, San Francisco	—
Completed	Understanding Dexmedetomidine In Infants Post-Operative From Cardiac Surgery NCT00573066	Athena Zuppa	Phase 1
Completed	Liothyronine in Children With Single Ventricle Congenital Cardiac Malformations Undergoing the Fontan Procedur NCT00004828	FDA Office of Orphan Products Development	Phase 1